Thema
Journal Article
32
Research Support, N.I.H., Extramural
27
Research Support, Non-U.S. Gov't
24
EC 2.7.10.1
23
ErbB Receptors
17
Protein Kinase Inhibitors
12
EGFR protein, human
9
Vascular Endothelial Growth Factor A
9
NSCLC
7
Quinazolines
7
EC 2.7.11.1
5
Antineoplastic Agents
4
Beta-adrenergic receptors
4
Beta-blockers
4
Catecholamines
4
Interleukin-6
4
Non–small cell lung cancer
4
Research Support, U.S. Gov't, Non-P.H.S.
4
Vascular Endothelial Growth Factor Receptor-2
4
2S9ZZM9Q9V
3
41UD74L59M
3
Afatinib
3
Angiogenesis Inhibitors
3
Bevacizumab
3
HM781-36B
3
Piperidines
3
Receptor, ErbB-2
3
Receptors, Vascular Endothelial Growth Factor
3
Research Support, U.S. Gov't, P.H.S.
3
YO460OQ37K
3
vandetanib
3
Adrenergic beta-Antagonists
2
Antibodies, Monoclonal
2
Antibodies, Monoclonal, Humanized
2
Clinical Trial, Phase II
2
DA87705X9K
2
EC 2.7.10.2
2
EC 2.7.11.24
2
Erlotinib Hydrochloride
2
Hypoxia-Inducible Factor 1, alpha Subunit
2
Norepinephrine
2
Protein Serine-Threonine Kinases
2
Proteome
2
Proto-Oncogene Proteins
2
Proto-Oncogene Proteins c-met
2
RNA, Messenger
2
Receptor Protein-Tyrosine Kinases
2
Receptors, Adrenergic, beta
2
Review
2
TOR Serine-Threonine Kinases
2
mehr ...